147 related articles for article (PubMed ID: 4858717)
1. Long-term establishment of a human plasmacyte cell line derived from a patient with IgD multiple myeloma. I. Requirement of a plasmacyte-stimulating factor for the proliferation of myeloma cells in tissue culture.
Jobin ME; Fahey JL; Price Z
J Exp Med; 1974 Aug; 140(2):494-507. PubMed ID: 4858717
[TBL] [Abstract][Full Text] [Related]
2. Multiple myeloma with monoclonal IgG and IgD of lambda type exhibiting, under treatment, a shift from mainly IgG to mainly IgD.
Gallart T; Bladé J; Martínez-Quesada J; Sierra J; Rozman C; Vives J
Immunology; 1985 May; 55(1):45-57. PubMed ID: 3922877
[TBL] [Abstract][Full Text] [Related]
3. The normal counterpart of IgD myeloma cells in germinal center displays extensively mutated IgVH gene, Cmu-Cdelta switch, and lambda light chain expression.
Arpin C; de Bouteiller O; Razanajaona D; Fugier-Vivier I; Brière F; Banchereau J; Lebecque S; Liu YJ
J Exp Med; 1998 Apr; 187(8):1169-78. PubMed ID: 9547329
[TBL] [Abstract][Full Text] [Related]
4. Myeloma with two monoclonal IgG and IgD in serum: a case report.
Franck P; Petitpain N; Guerci AP; Denisart S; Jacob C; Guéant JL
Acta Haematol; 1994; 92(3):144-7. PubMed ID: 7871954
[TBL] [Abstract][Full Text] [Related]
5. Double myeloma. Production of both IgG type lambda and IgA type lambda myeloma proteins by a single plasma cell line.
Rudders RA; Yakulis V; Heller P
Am J Med; 1973 Aug; 55(2):215-21. PubMed ID: 4124689
[No Abstract] [Full Text] [Related]
6. Characterization of new IgG lambda myeloma plasma cell line (EJM): a further tool in the investigation of the biology of multiple myeloma.
Hamilton MS; Ball J; Bromidge E; Lowe J; Franklin IM
Br J Haematol; 1990 Jul; 75(3):378-84. PubMed ID: 2117464
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal IgD. A comparative study of 60 sera with IgD "M" component.
Fine JM; Rivat C; Lambin P; Ropartz C
Biomedicine; 1974 Mar; 21(3):119-25. PubMed ID: 4429767
[No Abstract] [Full Text] [Related]
8. Individual serum proteins and acute phase reactants in monoclonal immunoglobulinopathies (a study in patients with IgA myeloma and light chain myeloma).
Wiedermann D; Widermann B; Cídl K; Scudla V
Neoplasma; 1979; 26(3):315-24. PubMed ID: 119165
[No Abstract] [Full Text] [Related]
9. A case of IgD myeloma representing a missed biclonal paraproteinemia or isotype switch in a patient previously diagnosed with IgA-lambda myeloma.
Chepovetsky J; Chari A; Jagannath S; Ramanthan L
Clin Chim Acta; 2013 Oct; 425():233-5. PubMed ID: 23954772
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the usefulness of measuring the serum and urine levels of light chain immunoglobulins in multiple myeloma and Waldenström's macroglobulinemia].
Kraj M; Maj S; Rostkowska J
Acta Haematol Pol; 1991; 22(1):21-30. PubMed ID: 1823963
[TBL] [Abstract][Full Text] [Related]
11. IgD myeloma presenting as a testicular tumor: establishment and characterization of an IgD-secreting myeloma cell line.
Ishii K; Yamato K; Kubonishi I; Taguchi H; Ohtsuki Y; Miyoshi I
Am J Hematol; 1992 Nov; 41(3):218-24. PubMed ID: 1329502
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of free lambda-chain of immunoglobulin produced by an established cell line of human myeloma cell origin. II. Identity of lambda-chains in cells and in medium.
Matsuoka Y; Yagi Y; Moore GE; Pressman D
J Immunol; 1969 Nov; 103(5):962-9. PubMed ID: 4187117
[No Abstract] [Full Text] [Related]
13. Establishment and characterization of new IgD lambda type myeloma cell lines, MOLP-2 and MOLP-3, expressing CD28, CD33 antigens and the IL-6 receptor.
Matsuo Y; Nakamura S; Adachi T; Tsubota T
Hum Cell; 1993 Dec; 6(4):310-3. PubMed ID: 8148313
[TBL] [Abstract][Full Text] [Related]
14. IgD multiple myeloma. Review of 133 cases.
Jancelewicz Z; Takatsuki K; Sugai S; Pruzanski W
Arch Intern Med; 1975 Jan; 135(1):87-93. PubMed ID: 1111472
[TBL] [Abstract][Full Text] [Related]
15. IgD myeloma with malignant pleural effusion.
Kamal MK; Williams E; Poskitt TR
South Med J; 1987 May; 80(5):657-8. PubMed ID: 3576276
[TBL] [Abstract][Full Text] [Related]
16. The frequency distribution of heavy chain classes and light chain types of 1,000 monoclonal immunoglobulins.
Creyssel R; Gibaud A; Cordier JF; Boissel JP
Biomedicine; 1975 Jan; 22(1):41-8. PubMed ID: 810190
[TBL] [Abstract][Full Text] [Related]
17. Differing surface marker characteristics in plasma cell dyscrasias with particular reference to IgM myeloma.
Burns GF; Cawley JC; Barker CR; Worman CP; Raper CG; Hayhoe FG
Clin Exp Immunol; 1978 Mar; 31(3):414-8. PubMed ID: 350460
[TBL] [Abstract][Full Text] [Related]
18. [Incomplete picture of protein disorders in IgD multiple myeloma].
Kraj M; Maj S; Mendek E; Snigurowicz J; Michalak T; Polkowska-Kulesza E
Acta Haematol Pol; 1982; 13(3-4):147-55. PubMed ID: 6820866
[No Abstract] [Full Text] [Related]
19. Characterization of antiserum against myeloma cells.
Cawley LP; Goodwin WL; Minard BJ
Cancer Res; 1973 Jan; 33(1):17-22. PubMed ID: 4629871
[No Abstract] [Full Text] [Related]
20. Correlation of abnormal immunoglobulin with clinical features of myeloma.
Arch Intern Med; 1975 Jan; 135(1):46-52. PubMed ID: 1111470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
